Heart Disease Structural Disorder clinical trials at UCSF
1 in progress, 0 open to eligible people
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Sorry, accepting new patients by invitation only
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or low risk for surgical mortality. The trial will also evaluate the safety and effectiveness of the Navitor TAVI System in a valve-in-valve (ViV) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve who are at high or greater surgical risk.
Stanford, California and other locations
Our lead scientists for Heart Disease Structural Disorder research studies include Sammy Elmariah.
Last updated: